Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Cholangiocarcinomas can originate from hepatocytes in mice

Open access

Abstract

Intrahepatic cholangiocarcinomas (ICCs) are primary liver tumors with a poor prognosis. The development of effective therapies has been hampered by a limited understanding of the biology of ICCs. Although ICCs exhibit heterogeneity in location, histology, and marker expression, they are currently thought to derive invariably from the cells lining the bile ducts, biliary epithelial cells (BECs), or liver progenitor cells (LPCs). Despite lack of experimental evidence establishing BECs or LPCs as the origin of ICCs, other liver cell types have not been considered. Here we show that ICCs can originate from fully differentiated hepatocytes. Using a mouse model of hepatocyte fate tracing, we found that activated NOTCH and AKT signaling cooperate to convert normal hepatocytes into biliary cells that act as precursors of rapidly progressing, lethal ICCs. Our findings suggest a previously overlooked mechanism of human ICC formation that may be targetable for anti-ICC therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci63212

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 538

Metadata

Authors
Fan, B., Malato, Y., Calvisi, D. F., Naqvi, S., Razumilava, N., Ribback, S., Gores, G. J., Dombrowski, F., Evert, M., Chen, X., & Willenbring, H.
Affiliations
  • University of California, San Francisco (US)
  • Universität Greifswald (DE)
  • Mayo Clinic (US)
Venue
Journal of Clinical Investigation
Published
2012-08-01
Volume
122
Issue
8
Pages
2911-2915
ISSN
0021-9738 (ISSN-L)
OpenAlex
W1986657600
Cited by
529
References
20
Citations by year
2026: 20 · 2025: 34 · 2024: 52 · 2023: 39 · 2022: 55 · 2021: 27 · 2020: 51 · 2019: 38 · 2018: 35 · 2017: 36 · 2016: 35 · 2015: 35 · 2014: 34 · 2013: 33 · 2012: 3
FWCI
34.29
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • California Institute for Regenerative Medicine
  • Deutsche Forschungsgemeinschaft (Do622/2-1, Ev168/2-1)
  • China Scholarship Council
  • National Institutes of Health (NIH-R01)
  • University of California, San Francisco (P30DK026743)
  • National Cancer Institute (R01CA136606)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK026743)
  • Liver Center, University of California, San Francisco (P30 DK026743)
Topics
  • Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
intrahepatic cholangiocarcinoma, Notch signaling, Akt signaling, cholangiocytes, liver progenitor cells, tumor cell of origin, mouse model, tumor heterogeneity
MeSH terms
Animals, Base Sequence, Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Cell Differentiation, Humans, Liver Neoplasms, Liver Neoplasms, Experimental, Mice, Transgenic, Recombinant Proteins, Neoplastic Stem Cells, Signal Transduction, DNA Primers, Cholangiocarcinoma, Cell Lineage, Hepatocytes, Proto-Oncogene Proteins c-akt, Mice, Receptors, Notch, Receptor, Notch1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cholangiocarcinomas can originate from hepatocytes in mice. https://app.cochat.ai/papers/10.1172/jci63212
The paper
Fan, B., Malato, Y., Calvisi, D. F., Naqvi, S., Razumilava, N., Ribback, S., Gores, G. J., Dombrowski, F., Evert, M., Chen, X., & Willenbring, H. (2012). Cholangiocarcinomas can originate from hepatocytes in mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci63212

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.